Thus, based on mRNA expression and clinical data from Oncomine and TCGA, we conclude that PROM1 has as an oncogenic role in brain, esophageal, ovarian, and gastric cancers and melanoma and PROM2 shows oncogenic behavior in lung and ovarian cancers (Fig. 8c). The gene discussed is PROM2; the disease is ovarian cancer.